Research in Dialysis Patients Consensus Conference - March 2006

Sponsored by:
American Society of Nephrology
National Kidney Foundation
Renal Physicians Association
National Institutes of Health

On March 21, 2006, the RPA, the NKF, and ASN organized a meeting that brought together physicians, representatives of pharmaceutical companies engaged in dialysis related research and dialysis provider, in order to engage in a dialogue that would enhance and facilitate the performance of research in dialysis patients. The deliberations and perspectives of the various constituencies are included below, as are the recommendations that emanated from the discussions. We are now actively working on putting these recommendations into place. We feel that this is an important step that will greatly benefit our patients with end stage renal disease, who are now afflicted with unacceptably high mortality rates.

Please note: perspectives appear below in their presentation order.

• Participant List
  
  
• Physician Perspectives
  Michael Allon, MD
  Allen R. Nissenson, MD, FASN
  Daniel Batlle, MD, FACP
  
  
• Dialysis Provider Perspectives
  DaVita (Randall Hein, GM)
  Renal Care Group (Raymond M. Hakim, MD, PhD)
  Fresenius Medical Care (John M. Lazarus, MD)
  
  
• Industry Perspectives
  Amgen (Robert M. Brenner, MD)
  Baxter (Dhreendra Kommala)
  Abbott (Laura Williams, MD)
  
  
• Legal Considerations
  Neil S. Olderman, JD (Gardner Carton & Douglas)
  
  
• Recommendations